Soligenix Eulerpool Ziņas

Soligenix Akciju Ziņas

Soligenix tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Soligenix ziņas mēs apkopojam šeit.

• 6. jūnijs ·

  Yahoo
  Soligenix Highlights Dr. Ellen Kim’s Recent Q&A and the Promise of HyBryte™ in Ongoing Clinical Trials
• 13. maijs ·

  Yahoo
  SNGX: Enrollment Continues in Confirmatory Phase 3 Trial of HyBryte™ in CTCL…
• 14. aprīlis ·

  Yahoo
  Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks
• 21. marts ·

  Yahoo
  Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results
• 6. marts ·

  Yahoo
  HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
• 24. februāris ·

  Yahoo
  SNGX: Presentation Highlights HyBryte Potential in CTCL…
• 4. februāris ·

  Yahoo
  Soligenix to Present at BIO CEO & Investor Conference
• 17. decembris ·

  Yahoo
  Soligenix begins enrolling subjects in cutaneous T-cell lymphoma treatment trial
• 17. decembris ·

  Yahoo
  Soligenix initiates confirmatory Phase 3 trial of HyBryte
• 16. decembris ·

  Yahoo
  SNGX: Phase 3 FLASH2 Trial of HyBryte in CTCL Underway…